While bulk TCR profiling indicated the presence of the NY-ESO-1-restricted TCR and coexpressed TCR clonotypes identified in the ACT infusion product, spatial profiling suggests that these T cells were located in areas of the tumor with low CTNNB1 expression levels and were not present in tumor areas with increased CTNNB1 expression. Here, CTNNB1 is linked to neoplasm.